Chandra Bhagat Pharma IPO vs HindPrakash Industries IPO

Comparison between Chandra Bhagat Pharma IPO and HindPrakash Industries IPO.

IPO Details

Chandra Bhagat Pharma IPO is a SME Fixed Price IPO proposed to list at BSE SME while HindPrakash Industries IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Chandra Bhagat Pharma IPO is up to ₹9.69 Cr whereas the issue size of the HindPrakash Industries IPO is up to ₹10.92 Cr. The final issue price of Chandra Bhagat Pharma IPO is ₹51.00 per share and of HindPrakash Industries IPO is ₹40.00 per share.

 Chandra Bhagat Pharma IPOHindPrakash Industries IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹51.00 per share₹40.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size2000 shares3000 shares
Fresh Issue Size19,00,000 shares27,30,000 shares
Fresh Issue Size (Amount)up to ₹9.69 Crup to ₹10.92 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total19,00,000 shares27,30,000 shares
Issue Size Total (Amount)up to ₹9.69 Crup to ₹10.92 Cr

IPO Timetable

Chandra Bhagat Pharma IPO opens on Jan 31, 2020, while HindPrakash Industries IPO opens on Jan 15, 2020. The closing date of Chandra Bhagat Pharma IPO and HindPrakash Industries IPO is Feb 06, 2020, and Jan 17, 2020, respectively.

 Chandra Bhagat Pharma IPOHindPrakash Industries IPO
Issue OpenJan 31, 2020Jan 15, 2020
Issue CloseFeb 06, 2020Jan 17, 2020
Basis Of Allotment (Tentative)Feb 11, 2020Jan 22, 2020
Initiation of Refunds (Tentative)Feb 13, 2020Jan 23, 2020
Credit of Share (Tentative)Feb 13, 2020Jan 24, 2020
Listing date (Tentative)Feb 14, 2020Jan 27, 2020

Financials & KPIs

Chandra Bhagat Pharma IPO P/E ratio is 51, as compared to HindPrakash Industries IPO P/E ratio of 11.7.

 Chandra Bhagat Pharma IPOHindPrakash Industries IPO
Financials

Company Financials (Restated)

Period Ended31 Jul 201931 Mar 201931 Mar 201831 Mar 2017
Assets85.9482.8658.0655.90
Total Income33.45106.7297.7390.28
Profit After Tax0.250.631.030.66
EBITDA1.474.674.754.39
NET Worth13.5313.288.017.41
Reserves and Surplus9.2613.708.036.99
Total Borrowing15.0117.6317.2210.62
Amount in ₹ Crore

Company Financials (Restated)

Period Ended30 Sep 201931 Mar 201931 Mar 201831 Mar 2017
Assets47.9348.1431.1634.67
Total Income50.6497.9987.4886.12
Profit After Tax1.782.832.322.14
EBITDA3.275.444.894.67
NET Worth21.2419.5116.6814.38
Reserves and Surplus13.6911.9614.5312.22
Total Borrowing13.1415.2511.4110.85
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)95.82%100%
Promoter Shareholding (Post-Issue)70.42%72.37%
P/E Ratio5111.7
Market Cap₹38.48 Cr.₹41.70 Cr.

Shares Offered

In the Chandra Bhagat Pharma IPO Retail Individual Investors (RII) are offered 9,50,000 shares while in HindPrakash Industries IPO retail investors are offered 9,50,000 shares. Qualified Institutional Buyers (QIB) are offered in Chandra Bhagat Pharma IPO and in HindPrakash Industries IPO.

 Chandra Bhagat Pharma IPOHindPrakash Industries IPO
Market Maker Reservation1,00,000 shares1,50,000 shares
NII9,50,000 shares13,65,000 shares
RII9,50,000 shares13,65,000 shares
Total19,00,000 shares27,30,000 shares

Bids Received (Subscription)

Chandra Bhagat Pharma IPO subscribed 1.65x in total, whereas HindPrakash Industries IPO subscribed 2.16x.

Compare with others

Compare:

Chandra Bhagat Pharma IPO Vs HindPrakash Industries IPO